HK1041691B - 新的2-(n-氰基亞氨基)噻唑烷-4-酮衍生物 - Google Patents

新的2-(n-氰基亞氨基)噻唑烷-4-酮衍生物

Info

Publication number
HK1041691B
HK1041691B HK02102951.1A HK02102951A HK1041691B HK 1041691 B HK1041691 B HK 1041691B HK 02102951 A HK02102951 A HK 02102951A HK 1041691 B HK1041691 B HK 1041691B
Authority
HK
Hong Kong
Prior art keywords
group
alkyl group
atom
hydrogen atom
branched
Prior art date
Application number
HK02102951.1A
Other languages
English (en)
Other versions
HK1041691A1 (en
Inventor
米田文郎
大出博功
渡部真由美
安藤敬
安佐拓哉
上垣祐子
Original Assignee
藤本株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 藤本株式會社 filed Critical 藤本株式會社
Publication of HK1041691A1 publication Critical patent/HK1041691A1/xx
Publication of HK1041691B publication Critical patent/HK1041691B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70Sulfur atoms
    • C07D277/74Sulfur atoms substituted by carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cosmetics (AREA)
HK02102951.1A 1999-11-12 2002-04-19 新的2-(n-氰基亞氨基)噻唑烷-4-酮衍生物 HK1041691B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1999/006352 WO2001036402A1 (fr) 1998-07-14 1999-11-12 Nouveaux derives de 2-(n-cyano-imino)thiazolidin-4-one

Publications (2)

Publication Number Publication Date
HK1041691A1 HK1041691A1 (en) 2002-07-19
HK1041691B true HK1041691B (zh) 2004-12-24

Family

ID=14237278

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102951.1A HK1041691B (zh) 1999-11-12 2002-04-19 新的2-(n-氰基亞氨基)噻唑烷-4-酮衍生物

Country Status (15)

Country Link
US (1) US6380229B1 (zh)
EP (1) EP1142885B1 (zh)
JP (1) JP4285723B2 (zh)
KR (1) KR100608416B1 (zh)
CN (1) CN1159305C (zh)
AT (1) ATE345332T1 (zh)
AU (1) AU767923C (zh)
CA (1) CA2355243C (zh)
DE (1) DE69934027T2 (zh)
DK (1) DK1142885T3 (zh)
ES (1) ES2276547T3 (zh)
HK (1) HK1041691B (zh)
IL (1) IL144229A (zh)
PT (1) PT1142885E (zh)
WO (1) WO2001036402A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383347A1 (en) 1999-08-31 2001-03-08 Maxia Pharmaceuticals, Inc. Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
JP2001199888A (ja) * 2000-01-24 2001-07-24 Fujimoto Brothers:Kk 糖尿病治療剤
IL157740A0 (en) 2001-03-07 2004-03-28 Incyte San Diego Inc Heterocyclic derivatives and pharmaceutical compositions containing the same
US7265139B2 (en) 2001-03-08 2007-09-04 Incyte San Diego Inc. RXR activating molecules
JP2004530690A (ja) 2001-05-16 2004-10-07 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 抗炎症性薬剤として有用なジアリールウレア誘導体
AU2002352706A1 (en) 2001-11-15 2003-06-10 Maxia Pharmaceuticals, Inc. N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
AR037714A1 (es) * 2001-12-06 2004-12-01 Maxia Pharmaceuticals Inc Derivados de tiazolidinona y oxazolidinona 2-sustituidos para la inhibicion de fosfatasas y el tratamiento de cancer
US7102000B2 (en) 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US7196108B2 (en) 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
SI1689726T1 (sl) 2003-11-21 2011-01-31 Actelion Pharmaceuticals Ltd Derivati 5-(benz-(z)-iliden)-tiazolidin-4-ona kot imunosupresivna sredstva
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
CN101541772B (zh) * 2006-11-23 2013-04-17 埃科特莱茵药品有限公司 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
CN103450077B (zh) * 2007-06-08 2016-07-06 满康德股份有限公司 IRE-1α抑制剂
JP6322630B2 (ja) 2012-08-17 2018-05-09 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd (2Z,5Z)−5−(3−クロロ−4−((R)−2,3−ジヒドロキシプロポキシ)ベンジリデン)−2−(プロピルイミノ)−3−(o−トリル)チアゾリジン−4−オンの製造方法及び前記方法において使用される中間体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07165371A (ja) 1993-10-06 1995-06-27 Japan Tobacco Inc テープ巻き付け方法および装置
JPH0892249A (ja) * 1994-07-20 1996-04-09 Sankyo Co Ltd スルホンアミド誘導体
JP3871354B2 (ja) * 1994-07-29 2007-01-24 株式会社フジモト・コーポレーション 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
JPH08157461A (ja) * 1994-12-07 1996-06-18 Sankyo Co Ltd スルホン誘導体
JPH09165371A (ja) 1995-10-09 1997-06-24 Sankyo Co Ltd 複素環化合物を含有する医薬
ATE231136T1 (de) * 1996-04-09 2003-02-15 Reddys Lab Ltd Dr Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften, verfahren zu deren herstellung und pharmazeutischen zusammenstellungen, die sie enthalten
JP2000026438A (ja) * 1998-07-14 2000-01-25 Fujimoto Brothers:Kk 新規な2−(n−シアノイミノ)チアゾリジン−4− オン誘導体

Also Published As

Publication number Publication date
CA2355243A1 (en) 2001-05-25
CN1333762A (zh) 2002-01-30
KR100608416B1 (ko) 2006-08-02
JP4285723B2 (ja) 2009-06-24
ATE345332T1 (de) 2006-12-15
AU1180100A (en) 2001-05-30
EP1142885A1 (en) 2001-10-10
HK1041691A1 (en) 2002-07-19
AU767923C (en) 2005-03-24
DE69934027D1 (de) 2006-12-28
IL144229A0 (en) 2002-05-23
DE69934027T2 (de) 2007-06-21
WO2001036402A1 (fr) 2001-05-25
EP1142885A4 (en) 2003-01-29
EP1142885B1 (en) 2006-11-15
IL144229A (en) 2006-10-05
ES2276547T3 (es) 2007-06-16
DK1142885T3 (da) 2007-02-26
PT1142885E (pt) 2007-02-28
KR20010108089A (ko) 2001-12-07
AU767923B2 (en) 2003-11-27
CN1159305C (zh) 2004-07-28
CA2355243C (en) 2009-01-27
US6380229B1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
AU767923C (en) Novel 2-(N-cyanoimino)thiazolidin-4-one derivatives
EP0749974A4 (en) PHOSPHONIC DIESTER DERIVATIVE
IL192605A0 (en) 1,2-dihydropyridin-2-one derivatives and pharmaceutical compositions containing the same
DE69624143D1 (de) Phosphonsaurediester-derivate
DE69613710T2 (de) Benzoxazepinverbindungen, ihre herstellung und verwendung als lipidsenker
ATE223411T1 (de) 1-methylcarbapenem-derivate
ES2089041T5 (es) Compuestos de piridinasulfonamida sustituida, composiciones herbicidas que los contienen, y procedimiento para su preparacion.
IL145336A0 (en) Therapeutic agents for diabetes
WO2001044207A8 (fr) Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
GR3036029T3 (en) Optically active thiazolidinone derivatives
DE69915471D1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
AU7332996A (en) Therapeutics for thrombocytopenia
HU9600597D0 (en) 4-alkylthio-pyrimidin-5-yl acetic acid derivates and fungicidal compositions containing them as an active ingredient
CA2225624A1 (en) Hydrazine derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141112